skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I am a multi-year owner of this company. I read your recent report and was surprised to see that Mawer owned such a large position (must have missed it previously). I consider them one of the better money managers out there so on the one hand, I consider their position a plus. But it does make wonder about a few things.

Is it common for a fund company to own such a significant position in a small cap name? CXI is a very thinly traded stock so how does Mawer exit other than through a takeover since selling out their position would likely decimate the stock price? Would this have been their plan all along or have they accumulated this position over the years suggesting they are believing in the story more and more? Would Mawer be an active or at least "very interested", party as to how the company is run? In sum, does having Mawer own so much change or affect how we should view this stock?

Appreciate your insight.

Paul F.
Read Answer Asked by Paul on June 04, 2018
Q: I have 6% of portflio in ENB. Will it be better to sell 50% of ENB and buy KEY for better risk management and capital appreciation. Although ENB pays 2% more dividend.
OR
Will it be prudent to sell half or all of ENB and buy CSU?
Thank you, kam
Read Answer Asked by KAM on June 04, 2018
Q: I'm way under water on these three stocks. I've held them for more than a year. Is there any point at this time to continue to hold any of them or should I just cut my losses and move on? Any suggestions for better (actual) growth in the same sectors?
Read Answer Asked by Brian on June 04, 2018
Q: When will you be updating the model portfolios for May 2018? Ernie
Read Answer Asked by Ernie on June 04, 2018
Q: I am holding a position in this company waiting to see what the acquisition of Cardiome Pharma will look like - meaning will this put CPH on a path to higher earning. However the stock price is finding new 52 week lows. Would your advice be sell now or give them a quarter or two to see what this acquisition is going to look like?
Read Answer Asked by Harry on June 04, 2018
Q: hi Peter know you do not follow US companies but wondered if you had any general thoughts about the recent further investment by Fairfax in SSW(now up to 1 billion USD). the shares trade at under 14X and with a div of .50 cents yield 5.59%. the CEO is a former senior executive with Berkshire Hathaway SSW is using the capital infusion to buy or create strategic partnerships with competitor companies not sure about debt/equity thanks for your input Richard.
Read Answer Asked by richard on June 04, 2018
Q: ZYME has dropped 12% rather abruptly this morning but I can't find any relevant news on-line. Do you know of any particular problems?

Thanks,
John
Read Answer Asked by John on June 04, 2018
Q: Website - Q&A - would it be possible to leave the screen at the top of the Question when you click on Answer. Pain to always scroll back up just to read question again
Read Answer Asked by David on June 04, 2018
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!